Skip to main content
AAPL+0.69%MSFT+0.96%GOOGL+1.78%NVDA+3.63%AMZN+1.69%SPCX+1.42%TSM+2.78%AVGO+2.47%META+1.21%TSLA+1.46%LLY+0.01%WMT+0.08%JPM-0.04%BRK-B0.00%V+0.01%SKHY0.00%AMD+3.30%MU+2.48%XOM0.00%JNJ+0.15%MA-0.02%ABBV+0.08%ASMLa-9.33%COST+0.19%1398.HK+0.25%KO+0.03%CVX+0.03%0700.HK-1.26%PG+0.09%CSCO+0.07%0939.HK0.00%HD+0.05%3988.HK-1.13%BAC+0.05%1816.HK+3.45%GE-0.03%0857.HK-0.49%ORCL-0.01%UNH+0.01%1288.HK-0.45%PM+0.02%0005.HK-3.08%NVS-0.01%HSBA.L-3.62%INTC+3.30%AZN-0.01%MS+0.02%RTX+0.02%ORp-0.36%TMO+0.14%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%CADJPY0.00%CHFJPY0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GBPSGD0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.92%ETHUSD+71.01%USDTUSD+0.13%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.17%ZECUSDT+2.12%XMRUSDT-0.26%DOGEUSD+69.80%LINKUSD+2.85%XLMUSD-0.53%BCHUSDT-0.40%LTCUSD+68.40%UNIUSD-0.10%TONUSD+79.92%SUIUSD+1.92%HBARUSDT+0.05%TAOUSDT+2.48%AAVEUSD+1.63%ONDOUSDT+1.26%DOTUSDT+2.07%ICPUSDT+2.00%WLDUSDT+2.88%ARBUSDT+2.21%ATOMUSDT+0.87%INJUSDT+4.02%STXUSDT+2.99%PYTHUSDT+4.25%TIAUSDT+2.74%FETUSDT+0.51%SEIUSDT+0.59%JUPUSDT+2.33%GRTUSDT+0.76%OPUSDT+1.55%IOTAUSDT+1.87%POLUSDT+0.52%WIFUSDT+1.51%AXSUSDT+0.33%EOSUSDT+0.60%IMXUSDT+0.09%FARTCOINUSDT+1.24%GALAUSDT+3.50%DYDXUSDT+0.63%ORDIUSDT+3.12%NOTUSDT+1.19%RONINUSDT+1.91%AAPL+0.69%MSFT+0.96%GOOGL+1.78%NVDA+3.63%AMZN+1.69%SPCX+1.42%TSM+2.78%AVGO+2.47%META+1.21%TSLA+1.46%LLY+0.01%WMT+0.08%JPM-0.04%BRK-B0.00%V+0.01%SKHY0.00%AMD+3.30%MU+2.48%XOM0.00%JNJ+0.15%MA-0.02%ABBV+0.08%ASMLa-9.33%COST+0.19%1398.HK+0.25%KO+0.03%CVX+0.03%0700.HK-1.26%PG+0.09%CSCO+0.07%0939.HK0.00%HD+0.05%3988.HK-1.13%BAC+0.05%1816.HK+3.45%GE-0.03%0857.HK-0.49%ORCL-0.01%UNH+0.01%1288.HK-0.45%PM+0.02%0005.HK-3.08%NVS-0.01%HSBA.L-3.62%INTC+3.30%AZN-0.01%MS+0.02%RTX+0.02%ORp-0.36%TMO+0.14%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%CADJPY0.00%CHFJPY0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GBPSGD0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.92%ETHUSD+71.01%USDTUSD+0.13%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.17%ZECUSDT+2.12%XMRUSDT-0.26%DOGEUSD+69.80%LINKUSD+2.85%XLMUSD-0.53%BCHUSDT-0.40%LTCUSD+68.40%UNIUSD-0.10%TONUSD+79.92%SUIUSD+1.92%HBARUSDT+0.05%TAOUSDT+2.48%AAVEUSD+1.63%ONDOUSDT+1.26%DOTUSDT+2.07%ICPUSDT+2.00%WLDUSDT+2.88%ARBUSDT+2.21%ATOMUSDT+0.87%INJUSDT+4.02%STXUSDT+2.99%PYTHUSDT+4.25%TIAUSDT+2.74%FETUSDT+0.51%SEIUSDT+0.59%JUPUSDT+2.33%GRTUSDT+0.76%OPUSDT+1.55%IOTAUSDT+1.87%POLUSDT+0.52%WIFUSDT+1.51%AXSUSDT+0.33%EOSUSDT+0.60%IMXUSDT+0.09%FARTCOINUSDT+1.24%GALAUSDT+3.50%DYDXUSDT+0.63%ORDIUSDT+3.12%NOTUSDT+1.19%RONINUSDT+1.91%
ME

Medpace Holdings, Inc. (MEDP)

NASDAQ • Healthcare

$610.54
-$23.44 (-3.7%)
Market open

Last close at November 20, 2026 at 21:00 UTC

Open$632.09
Previous Close$610.54
Day Range$606.73 - $633.87
Avg. Volume (3M)213.7K
Market Cap$17B
P/E Ratio33.3
52 Week Range
$373$693.97
Next EarningsIn 78 daysFeb 8, 2027

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$716M100%
Gross Profitminus cost of goods$223.8M31%
Operating Incomeminus R&D and overhead$165.5M23%
Net Incomeminus taxes and the rest$137.4M19%

In plain terms: out of every $100 in revenue, Medpace Holdings, Inc. keeps $19 as net profit.

Fundamentals & Financials

Revenue (TTM)
$2.8B
Net Income (TTM)
$517.8M
EPS (TTM)
$18.36
ROA (TTM)
22.49%
Current Ratio
0.83

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+9.2%Q2 2026$4.28
+6.8%Q3 2026$4.25
+9.0%Q4 2026$4.84
Next

Feb 8

in 78 daysQ1 2027

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +9.0%

Medpace’s preliminary third fiscal quarter of 2026 results, reported October 21, 2026, showed EPS of $4.84 topping the $4.44 estimate (+9%) while revenue of $716.0 million came in line with the $714.5 million estimate (+0.2%). Revenue rose ~9% year over year to roughly $716 million (up from about $660 million a year ago), reflecting continued demand for its outsourced clinical development and research services. Profitability stayed elevated, with gross margin at ~31% and operating margin at ~23% as gross profit reached about $223.9 million and operating income came in around $165.5 million. Net income increased ~24% year over year to roughly $137.5 million (up from about $111.1 million), alongside EPS up ~25% from $3.86 a year ago. Cash generation was notable as well, with operating cash flow of about $216.6 million for the quarter. For the next period, consensus calls for EPS of $4.64 on revenue of $720.9 million.

View full earnings history

About Medpace Holdings, Inc.

Medpace Holdings, Inc. provides outsourced clinical development and research services to drug, biotechnology, and medical-device companies, pairing trial management with laboratory and data capabilities across the healthcare research and diagnostics field. Listed on the NASDAQ as MEDP, the company recorded $2.5 billion of revenue in FY2025.

Name
Medpace Holdings, Inc.
CEO
August James Troendle
Industry
Healthcare
Year Founded
1992
Employees
6,600

Today's Snapshot

AI-generated

MEDP closed 3.7% lower on heavier trading than usual.

Trading Volume

Above 10d avg 179.3K

236.6K

vs S&P 500 Today

Moderate Underperformance

-0.21%

Updated: November 20, 2026 at 21:21 UTC

Technical Indicators

3 Buy1 Neutral4 Sell
MEDP is rated a sell with the price trading well below short- and medium-term moving averages while remaining above the longer 200-day band, a configuration that signals near-term weakness against a longer-term base. Momentum measures are skewed negative — the CCI is deeply negative and MACD is slightly below zero — and RSI sits in the lower range, indicating limited buying conviction. ADX shows a moderate trend, suggesting the downmove has structure rather than mere noise, while OBV and the classic pivot level both point to distribution with the pivot above the market. Technical takeaway: Sell — short-term bias remains bearish below key pivots and moving averages.
All signals
  • EMA (5 indicators)$567.62 - $646.58
    Sell
  • RSI (14)37.91
    Neutral
  • Stochastic %K (14, 3, 3)14.20
    Buy
  • MACD Level (12, 26)-0.19
    Sell

Peers & Related Assets

IQVIQVIA Holdings Inc.
$245.82-1.9%
CRLCharles River Laboratories International, Inc.
$314.32-4.2%
FTREFortrea Holdings Inc.
$18.55-7.9%
300759.SZPharmaron Beijing Co., Ltd.
WUXIFWuXi AppTec Co., Ltd.
603127.SSJoinn Laboratories(China)Co.,Ltd.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.